Table 3.
Association of clinical-pathological parameters with HPV infection
| Clinical-pathological parameters | Total Sample No. | Total HPV +ve (%) |
Single Infection No. (%) |
Multiple Infection No. (%) |
Total HPV16 +ve (%) |
Total HPV -ve (%) |
p-value |
|---|---|---|---|---|---|---|---|
| Histological Type | 0.002* | ||||||
| Cervicitis CINb1/2/3 Squamous Cell Carcinoma (SCCc) Adenocarcinoma |
10 15 92 5 |
7 (70) 11 (73.3) 88 (95.6) 5 (100) |
4 (40.0) 4 (26.6) 58 (63.0) 3 (60.0) |
3 (30.0) 7 (46.6) 28 (30.4) 2 (40.0) |
3 (30) 9 (60) 66 (71.7) 2 (40) |
3 (30.0) 4 (26.6) 4 (4.3) 0 (0.0) |
|
| FIGO Stagea (SCC) | 0.298 | ||||||
| I II III/IV |
10 38 30 |
10 (100) 36 (94.7) 27 (90.0) |
5 (50.0) 22 (57.8) 21 (70.0) |
5 (50.0) 14 (36.8) 6 (20) |
8 (80) 28 (73.6) 20 (66.6) |
0 (0.0) 1 (1.1) 3 (3.2) |
|
| Histological Differentiation | 0.554 | ||||||
| Well Moderate Poor |
33 32 8 |
32 (96.9) 30 (93.7) 7 (87.5) |
22 (66.6) 17 (53.1) 5 (62.5) |
9 (27.3) 13 (40.6) 2 (25) |
22 (66.6) 23 (71.8) 6 (75.0) |
1 (3.0) 2 (6.2) 1 (12.5) |
*
Significant at p value ≤ 0.05
a
FIGO stage was not known for all the samples.
b
CIN: Cervical intraepithelial neoplasia
c
SCC: Squamous cell carcinoma of the cervix